Litcius/Paper detail

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

Johan Burisch, Mirabella Zhao, Selwyn Odes, Peter De Cruz, Séverine Vermeire, Çharles N. Bernstein, Gilaad G. Kaplan, Dana Ďuricová, Dan Greenberg, Hans Olav Melberg, Mamoru Watanabe, Hyeong Sik Ahn, Laura E. Targownik, Valérie Pittet, Vito Annese, K.T. Park, Κωνσταντίνος Κατσάνος, Marte Lie Høivik, Željko Krznarić, María Chaparro, Edward V. Loftus, Péter L. Lakatos, Javier P. Gisbert, Willem A. Bemelman, Bjørn Moum, Richard B. Gearry, Michael D. Kappelman, Ailsa Hart, Marieke Pierik, Jane M. Andrews, Siew C. Ng, R. D’Incà, Pia Munkholm

2023˜The œLancet. Gastroenterology & hepatology191 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHepatologyHealth careInflammatory bowel diseaseUlcerative colitisProductivityDiseaseIntensive care medicineCommissionBusinessInternal medicineEconomic growthFinanceEconomicsInflammatory Bowel DiseaseMicroscopic ColitisTuberculosis Research and Epidemiology
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission | Litcius